Literature DB >> 25654042

Role and Efficacy of L-PRFmatrix in the Regeneration of Periodontal Defect: A New Perspective.

Anuroopa P1, Padmavathi Patil2, Vinaya Kumar R3, Krishna Kripal4.   

Abstract

The ultimate goal of periodontal therapy is to achieve complete wound healing and regeneration of the periodontal unit. The therapeutic use of L-PRF matrix constitutes a relatively new biotechnology that has been a breakthrough in the acceleration of hard and soft tissue healing. Platelet-rich fibrin (PRF) belongs to a new generation of platelet concentrates, with simplified processing and without biochemical blood handling. The slow polymerization during PRF preparation seems to generate a fibrin network very similar to the natural one. Such a network leads to a more efficient cell migration and proliferation and thus cicatrization. This article proposes an overview of use of platelet-rich fibrin in management of periodontal hard and soft tissue defects and goes on to describe the clinical benefits of PRF and its advantage over PRP.

Entities:  

Keywords:  Blood products; L-PRF matrix; PRP; Periodontal defects; Regeneration

Year:  2014        PMID: 25654042      PMCID: PMC4316348          DOI: 10.7860/JCDR/2014/9240.5245

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

1.  Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features.

Authors:  David M Dohan; Joseph Choukroun; Antoine Diss; Steve L Dohan; Anthony J J Dohan; Jaafar Mouhyi; Bruno Gogly
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-01-10

2.  Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution.

Authors:  David M Dohan; Joseph Choukroun; Antoine Diss; Steve L Dohan; Anthony J J Dohan; Jaafar Mouhyi; Bruno Gogly
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-01-19

3.  Treatment of 3-wall intrabony defects in patients with chronic periodontitis with autologous platelet-rich fibrin: a randomized controlled clinical trial.

Authors:  Anuj Sharma; A R Pradeep
Journal:  J Periodontol       Date:  2011-04-05       Impact factor: 6.993

4.  Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts.

Authors:  I-Chang Chang; Chung-Hung Tsai; Yu-Chao Chang
Journal:  J Biomed Mater Res A       Date:  2010-10       Impact factor: 4.396

Review 5.  Platelet rich fibrin: a new paradigm in periodontal regeneration.

Authors:  R Vinaya Kumar; N Shubhashini
Journal:  Cell Tissue Bank       Date:  2012-11-11       Impact factor: 1.522

6.  Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months.

Authors:  Ziv Mazor; Robert A Horowitz; Marco Del Corso; Hari S Prasad; Michael D Rohrer; David M Dohan Ehrenfest
Journal:  J Periodontol       Date:  2009-12       Impact factor: 6.993

7.  A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro.

Authors:  Ling He; Ye Lin; Xiulian Hu; Yu Zhang; Hui Wu
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-11

8.  Platelet-rich-fibrin: A novel root coverage approach.

Authors:  K Anilkumar; A Geetha; T Ramakrishnan; R Vijayalakshmi; E Pameela
Journal:  J Indian Soc Periodontol       Date:  2009-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.